PEDIATRICS Vol. 22 No. 2 August 1958, pp. 296
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

How Many Injections of Poliomyelitis Vaccine for Effective and Durable Immunity?

The author presents evidence that antibody against poliomyelitis virus may be expected in the serum for a number of years after an effective course of immunization with poliomyelitis vaccine. The level of antibody induced after the booster dose is influenced by the amount of antigen which was administered in the primary vaccination as well as by the amount of antigen contained in the booster dose. The persistence of antibody is influenced similarly. Thus the answer to the question posed by the title of the paper is in part dependent upon the potency of the vaccine used in the primary vaccination and in the booster dose. Apparently all lots of commercially-prepared vaccine have not been of optimal potency. After considering all the theoretic and practical aspects of the problem the author indicates that the answer to the question "Should a fourth dose be given?" is answered in part by the assertion that it will do no harm. Without a knowledge of the degree of protection afforded by the primary immunization and a subsequent dose, the physician will be inclined to give a fourth dose of poliomyelitis vaccine as a booster to gain further assurance of protection. It is estimated that this will be of additional benefit to no more than 10% of those who have received three injections of the vaccine. There does not appear to be sufficient epidemiologic grounds upon which to base an aggressive campaign for universal application of a fourth injection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?